Filing Details

Accession Number:
0001181431-13-001253
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-03 17:50:22
Reporting Period:
2012-09-07
Filing Date:
2013-01-03
Accepted Time:
2013-01-03 17:50:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389870 Omni Bio Pharmaceutical Inc. OMBP Biological Products, (No Disgnostic Substances) (2836) 208097969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1327324 E D Vicki Barone 5350 South Roslyn
Suite 430
Greenwood Village CO 80111
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-07 100,000 $1.14 1,042,750 No 4 P Indirect By GVC Partners LLC
Common Stock Disposition 2012-09-07 125,000 $0.25 917,750 No 4 J Indirect By GVC Partners LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By GVC Partners LLC
No 4 J Indirect By GVC Partners LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-12 6,375 $0.00 6,375 $1.00
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-12 6,375 $0.00 6,375 $1.50
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-14 3,600 $0.00 3,600 $1.00
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-14 3,600 $0.00 3,600 $1.50
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-12 19,124 $0.00 19,124 $1.00
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-12 19,124 $0.00 19,124 $1.50
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-14 10,800 $0.00 10,800 $1.00
Common Stock Warrants (Right to Buy) Acquisiton 2012-12-14 10,800 $0.00 10,800 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,375 2012-12-12 2017-07-31 No 4 A Direct
6,375 2012-12-12 2017-07-31 No 4 A Direct
3,600 2012-12-14 2017-10-31 No 4 A Direct
3,600 2012-12-14 2017-10-31 No 4 A Direct
19,124 2012-12-12 2017-07-31 No 4 A Indirect
19,124 2012-12-12 2017-07-31 No 4 A Indirect
10,800 2012-12-14 2017-10-31 No 4 A Indirect
10,800 2012-12-14 2017-10-31 No 4 A Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 637,437 Direct
Footnotes
  1. Represents shares transferred to a third party in connection with a settlement agreement.
  2. The reporting person is a Senior Managing Partner of GVC Partners LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.
  3. Represents warrants issued by the issuer for services as placement agent in a private placement transaction of the issuer.